A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.
CAR NK biotech Catamaran Bio to wind down, will seek partners for cell therapies
Off-the-shelf cell therapy biotech Catamaran Bio made a “recent decision to commence wind-down,” CEO Alvin Shih told Endpoints News in an email on Monday. The